JFT RESEARCH LABS / EU
Bremelanotide activates melanocortin receptors involved in sexual response.
In the US a specific prescription formulation is used for acquired, generalised hypoactive sexual desire disorder in premenopausal women. Treatment aims to improve desire and reduce related distress.
Other names: PT-141 · Bremelanotide
Price per unit · €66.00
How to read a certificate of analysis (COA) · Analysis certificates
For Research Use Only